Tirzepsema 34mg

Tirzepsema 34mg

R 2,150.00
R 2,150.00
Skip to product information
Tirzepsema 34mg
  • Tirzepsema 34mg
  • Tirzepsema 34mg
Tirzepsema 34mg

Tirzepsema 34mg

R 2,150.00
R 2,150.00

Tirzepsema 34 mg combines 30 mg of Tirzepatide (a dual GIP + GLP-1 receptor agonist) with 4 mg of Semaglutide (a GLP-1 receptor agonist) in one weekly pre-filled pen. This “stacked” formulation is designed to deliver enhanced appetite control, metabolic boosting and body-composition support.

Key Benefits

  • Helps reduce hunger, cravings and “food noise” by activating multiple hormonal pathways.

  • Supports improved insulin sensitivity and metabolic regulation – ideal for clients targeting transformation beyond simple weight loss.

  • Weekly pre-filled pen format offers simplicity, precision, and convenience.

  • High-performance formulation that matches the BioHaven ethos of premium results, elevated aesthetic and scientific foundation.

Product Specifications

  • Active Ingredients: 30 mg Tirzepatide + 4 mg Semaglutide per pen.

  • Format: Pre-filled injection pen, once weekly use (under professional guidance).

  • Storage: Refrigerate unopened at 2–8 °C; follow usage instructions and rotate injection sites.

  • Intended Use: For adult clients under qualified oversight, as part of a comprehensive lifestyle programme (nutrition, exercise, recovery).

How to Use

  1. Under professional supervision, begin with appropriate dose protocol and maintain consistent weekly schedule.

  2. Choose injection site (abdomen, upper thigh or arm); rotate site each week for tissue health.

  3. Pair the pen with structured support: clean nutrition, resistance training, hydration, recovery.

  4. Monitor key markers: appetite control, body-composition changes, energy levels, metabolic health.

Safety & Considerations

  • Use only under medical/clinical supervision; verify source and legality. The South African Health Products Regulatory Authority (SAHPRA) has issued warnings regarding unregistered or counterfeit GLP-1/GIP products.

  • Possible side-effects: nausea, digestive changes, early‐dose adjustment required for tolerability.

  • Not a stand-alone product — maximum results require aligned lifestyle support.

  • Ensure appropriate screening (thyroid history, pancreas/liver health, etc) and clear disclosure to the client

Disclaimer: This product is supplied strictly for laboratory research purposes only. Not intended for human or animal consumption. Not a medicine.

You may also like